The bill to raise the debt ceiling and reduce the deficit would slash billions of dollars for basic scientific and medical research.
Advertisement
The Scientist
Most Recent
A new report says the FDA’s current oversight of medical devices is inadequate and should be revamped.
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
A new study suggests that new cancer treatments generally go on sale in the United States before they reach European markets
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
